Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBT (2021 - 2025)

Historic EBT for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$8.0 million.

  • MDxHealth's EBT rose 2615.38% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.7 million, marking a year-over-year increase of 2389.64%. This contributed to the annual value of -$37.7 million for FY2024, which is 1255.71% up from last year.
  • According to the latest figures from Q3 2025, MDxHealth's EBT is -$8.0 million, which was up 2615.38% from -$7.8 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's EBT ranged from a high of -$6.8 million in Q4 2024 and a low of -$18.1 billion during Q2 2022
  • Moreover, its 5-year median value for EBT was -$10.0 million (2023), whereas its average is -$1.1 billion.
  • Its EBT has fluctuated over the past 5 years, first tumbled by 7886.1% in 2022, then surged by 9994.13% in 2023.
  • MDxHealth's EBT (Quarter) stood at -$8.1 million in 2021, then plummeted by 52.31% to -$12.3 million in 2022, then grew by 12.92% to -$10.7 million in 2023, then skyrocketed by 36.63% to -$6.8 million in 2024, then dropped by 18.0% to -$8.0 million in 2025.
  • Its last three reported values are -$8.0 million in Q3 2025, -$7.8 million for Q2 2025, and -$9.1 million during Q1 2025.